Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Hope Rugo

Breast Oncology · City of Hope

View

Dr. Virginia Borges

Breast Oncology · CU Anschutz Medical Campus

View

Dr. William Gradishar

Breast Oncology · NU

View

Dr. Azka Ali

Breast Oncology · Cleveland Clinic Lerner

View

Dr. Amy Comander

Breast Oncology · PHS

View

Dr. Paolo Tarantino

Breast Oncology · Dana-Farber Cancer Institute

View

Dr. Anastasia Martynova

Breast Oncology · USC

View

Dr. Rani Bansal

Breast Oncology · Duke

View

Dr. Gilbert Bader

Breast Oncology · OSUMC

View

Dr. VK Gadi

Breast Oncology · UI Health

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms
    JADr. Jame Abraham
    Leading Voice

    Dr. Jame Abraham

    Hematology & Oncology · Breast Oncology
    Cleveland Clinic
    jame

    Research

    EPR25-121: Clonal Hematopoiesis of Indeterminate Potential (CHIP) in Cancer Patients: Testing and Referral Guidelines

    2025

    Via Journal of the National Comprehensive Cancer Network

    Research

    Human Epidermal Growth Factor Receptor 2 Positivity a Moving Target in the Era of Antibody-Drug Conjugates

    2025

    Via JCO Oncology Practice

    Research

    NCCN Guidelines® Insights: Breast Cancer, Version 5.2025

    2025

    Via Journal of the National Comprehensive Cancer Network

    Research

    Phase II Clinical Trial of Pembrolizumab and Chemotherapy Reveals Distinct Transcriptomic Profiles by Radiologic Response in Metastatic Triple-Negative Breast Cancer

    2024

    Via Clinical Cancer Research

    Research

    NSABP FB-10: a phase Ib/II trial evaluating ado-trastuzumab emtansine (T-DM1) with neratinib in women with metastatic HER2-positive breast cancer

    2024

    Via Breast Cancer Research

    Research

    Breast Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology

    2024

    Via Journal of the National Comprehensive Cancer Network

    Research

    Current and Novel Treatment Options in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer

    2024

    Via JCO Oncology Practice

    Research

    A 7-Gene Biosignature for Ductal Carcinoma in situ of the Breast Identifies Subpopulations of HER2-positive Patients With Distinct Recurrence Rates After Breast-Conserving Surgery and Radiation Therapy

    2024

    Via Clinical Breast Cancer

    Research

    Awareness, Knowledge, and Treatment Patterns of Nonmetastatic Inflammatory Breast Cancer in Low- and Middle-Income Countries: The BRIDGES Study

    2024

    Via JCO Global Oncology

    Research

    NCCN Guidelines® Insights: Breast Cancer, Version 4.2023

    2023

    Via Journal of the National Comprehensive Cancer Network

    Research

    Radiomic predicts early response to CDK4/6 inhibitors in hormone receptor positive metastatic breast cancer

    2023

    Via NPJ Breast Cancer

    Research

    Association of Bariatric Surgery With Cancer Risk and Mortality in Adults With Obesity

    2022

    Via JAMA

    Research

    Breast Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology

    2022

    Via Journal of the National Comprehensive Cancer Network

    Research

    Novel Radiomic Measurements of Tumor-Associated Vasculature Morphology on Clinical Imaging as a Biomarker of Treatment Response in Multiple Cancers

    2022

    Via Clinical Cancer Research

    Research

    Immune checkpoint inhibition in early-stage triple-negative breast cancer

    2022

    Via Expert Review of Anticancer Therapy